Clinical trials: Neuropsychological Test
COVID-19
A Two Year Longitudinal Clinical Study of Neurocognitive and Psychiatric Symptoms in Post COVID-19 Patients
The prospective, longitudinal, open observational study monitors patients with cognitive and neuropsychological symptoms after COVID-19 infection, in a longitudinal manner to see how the disease has affected their physical…
- Trial name
- PASC24 (NCT06298006)
- Testing
- Follow-up
- Where
- Sweden
- Volunteers
- 57 people
- Sponsor
- Region Örebro County
Alzheimer Disease, Biomarkers / Blood
Blood Biomarkers for Early and Accurate Diagnosis of Alzheimer's Disease in Primary Care
Alzheimer's disease is a degenerative condition affecting the brain and is the most common form of dementia in older adults. Dementia is currently a major healthcare issue in the UK, affecting approximately a million people.
- Conditions
- Alzheimer Disease, Biomarkers / Blood, Biomarker in Early Diagnosis, Mild Cognitive Impairment (MCI)
- Trial name
- BEAD-PC (NCT07401849)
- Volunteers
- 1,000 people
- Sponsor
- Imperial College London
Healthy Elderly
Study to Validate a Computerized Neuropsychological Test Battery
This study is comparing a new computer-based method of administering neuropsychological tests to the standard method of verbal and paper/pencil tests administered in person by an examiner.
- Trial name
- NCT01421446
- Where
- United States
- Volunteers
- 1 people, healthy volunteers welcome
- Sponsor
- LifeBridge Health
Early Onset Alzheimer Disease
Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease (MNEMOSYNE)
The purpose of this study is to evaluate the efficacy of NKO™ softgels in reducing decline of global cognitive function as measured by the Neuropsychological Test Battery (NTB), in patients diagnosed with early stage Alzheimer's…
- Trial name
- MNEMOSYNE (NCT00867828)
- Testing
- Neptune Krill Oil, Fish Oil
- Where
- 14 sites in Canada
- Volunteers
- 175 people
- Sponsor
- NeuroBioPharm Inc.
Schizotypal Personality Disorder, SPD
CRT-Guanfacine for SPD
This is a study to assess the efficacy augmenting cognitive remediation therapy (CRT) with a pharmacological agent for individuals with schizotypal personality disorder (SPD).
- Trial name
- NCT02524899
- Testing
- Cognitive Remediation Therapy, Guanfacine
- Where
- United States
- Volunteers
- 45 people, healthy volunteers welcome
- Sponsor
- Icahn School of Medicine at Mount Sinai
Alzheimer Disease, Parkinson Disease
The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180)
The complex pathological cascades leading to both Alzheimer's disease (AD) and Parkinson's disease (PD) involve, at various points, inflammation.
- Conditions
- Alzheimer Disease, Parkinson Disease, Inflammation
- Trial name
- NCT03702816
- Testing
- GE180 PET Scan
- Where
- United States
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Aaron Ritter, MD
Postoperative Cognitive Dysfunction
Post Cardiac Surgery Neurocognitive Decline: Correlations Between Neuropsychological Tests and Functional MRI Techniques
Postoperative cognitive decline (POCD) is a frequent complication after cardiac surgery. It is estimated that 40-70% of all cardiac patients show cognitive dysfunction during the first post-surgical week.
- Trial name
- CardChNeuroMRI (NCT01622452)
- Volunteers
- 50 people
- Sponsor
- Fondazione Toscana Gabriele Monasterio
Cognitive Assessment
Remote Testing in Abbiategrasso (RTA)
The remote cognitive assessment has the advantage of reaching people despite the restrictions due to the pandemic, so it is of fundamental importance both in the treatment of dementia and the research context.
- Trial name
- RTA (NCT05135806)
- Where
- Italy
- Volunteers
- 58 people, healthy volunteers welcome
- Sponsor
- Fondazione Golgi Cenci
Cognitive Impairment
Pilot Testing a New Computer-based Screening Tool to Detect Cognitive Impairment
A computer-based neuropsychological assessment tool is being developed to help primary care physicians detect neurological and psychiatric disorders.
- Trial name
- NCT01220674
- Testing
- cognitive testing
- Where
- United States
- Volunteers
- 152 people, healthy volunteers welcome
- Sponsor
- University of Nebraska
Transcranial Magnetic Stimulation, Magnetic Resonance Imaging
Brain Stimulation for Concussion
The goal of this clinical trial is to test a new type of magnetic brain stimulation in patients with persistent post-concussive symptoms.
- Conditions
- Transcranial Magnetic Stimulation, Magnetic Resonance Imaging, Neuropsychological Tests, Traumatic Brain Injury
- Trial name
- NCT05889117
- Testing
- Intermittent theta-burst treatment (iTBS) using MagPro Transcranial Magnetic Stimulator (manufacturer: Magventure)
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- The Mind Research Network